SCHEMBL8307351

SCHEMBL8307351

OCCON=Cc1cnc2ccccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.50
KMT2A Q03164 3/20 0.49
KDM4E B2RXH2 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
PDGFRB P09619 1/20 0.49
PDGFRA P16234 1/20 0.49
ADORA2A P29274 1/20 0.47
MET P08581 1/20 0.44
ALDH1A1 P00352 5/20 0.41
GAA P10253 2/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP1A2 P05177 3/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
PRKAG1 P54619 1/20 0.39
PRKAA1 Q13131 1/20 0.39
PRKAB1 Q9Y478 1/20 0.39
MAPK8 P45983 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307350 1.00 RAB9A (0.50) RAB9AKMT2AKDM4ESMN1; SMN2PDGFRB
SCHEMBL8307153 0.79 ALDH1A1 (0.54) KMT2AKDM4ESMN1; SMN2ALDH1A1GAA
SCHEMBL8307151 0.79 ALDH1A1 (0.54) KMT2AKDM4ESMN1; SMN2ALDH1A1GAA
SCHEMBL12757022 0.79 KDM4E (0.57) RAB9AKMT2AKDM4ESMN1; SMN2PDGFRB
SCHEMBL5904872 0.77 PDGFRB (0.59) RAB9AKMT2AKDM4ESMN1; SMN2PDGFRB
SCHEMBL5904869 0.77 PDGFRB (0.59) RAB9AKMT2AKDM4ESMN1; SMN2PDGFRB
SCHEMBL8306343 0.74 TAAR1 (0.47) RAB9AKMT2ASMN1; SMN2ALDH1A1GAA
SCHEMBL8306342 0.74 TAAR1 (0.47) RAB9AKMT2ASMN1; SMN2ALDH1A1GAA
SCHEMBL8305371 0.74 NPC1 (0.57) RAB9AKMT2AKDM4ESMN1; SMN2ADORA2A
SCHEMBL8305368 0.74 NPC1 (0.57) RAB9AKMT2AKDM4ESMN1; SMN2ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed